482 related articles for article (PubMed ID: 17622581)
1. Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism.
Manolagas SC; Almeida M
Mol Endocrinol; 2007 Nov; 21(11):2605-14. PubMed ID: 17622581
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription.
Almeida M; Han L; Martin-Millan M; O'Brien CA; Manolagas SC
J Biol Chem; 2007 Sep; 282(37):27298-27305. PubMed ID: 17623658
[TBL] [Abstract][Full Text] [Related]
3. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
Jin T; George Fantus I; Sun J
Cell Signal; 2008 Oct; 20(10):1697-704. PubMed ID: 18555664
[TBL] [Abstract][Full Text] [Related]
4. Should I stay or should I go: beta-catenin decides under stress.
Hoogeboom D; Burgering BM
Biochim Biophys Acta; 2009 Dec; 1796(2):63-74. PubMed ID: 19268509
[TBL] [Abstract][Full Text] [Related]
5. FoxOs, Wnts and oxidative stress-induced bone loss: new players in the periodontitis arena?
Galli C; Passeri G; Macaluso GM
J Periodontal Res; 2011 Aug; 46(4):397-406. PubMed ID: 21332475
[TBL] [Abstract][Full Text] [Related]
6. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity.
Hoogeboom D; Essers MA; Polderman PE; Voets E; Smits LM; Burgering BM
J Biol Chem; 2008 Apr; 283(14):9224-30. PubMed ID: 18250171
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of the Wnt/beta-catenin/TCF pathway by in vivo interferon-alpha2b (IFN-alpha2b) treatment in preneoplastic rat livers.
Parody JP; Alvarez ML; Quiroga AD; Ceballos MP; Frances DE; Pisani GB; Pellegrino JM; Carnovale CE; Carrillo MC
Growth Factors; 2010 Jun; 28(3):166-77. PubMed ID: 20109105
[TBL] [Abstract][Full Text] [Related]
8. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC
Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938
[TBL] [Abstract][Full Text] [Related]
9. FOXOs attenuate bone formation by suppressing Wnt signaling.
Iyer S; Ambrogini E; Bartell SM; Han L; Roberson PK; de Cabo R; Jilka RL; Weinstein RS; O'Brien CA; Manolagas SC; Almeida M
J Clin Invest; 2013 Aug; 123(8):3409-19. PubMed ID: 23867625
[TBL] [Abstract][Full Text] [Related]
10. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
11. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
Peröbner I; Karow M; Jochum M; Neth P
Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
[TBL] [Abstract][Full Text] [Related]
12. TCFs and Wnt/β-catenin signaling: more than one way to throw the switch.
Cadigan KM
Curr Top Dev Biol; 2012; 98():1-34. PubMed ID: 22305157
[TBL] [Abstract][Full Text] [Related]
13. The WNT signalling pathway and diabetes mellitus.
Jin T
Diabetologia; 2008 Oct; 51(10):1771-80. PubMed ID: 18696049
[TBL] [Abstract][Full Text] [Related]
14. The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans.
Marchand A; Atassi F; Gaaya A; Leprince P; Le Feuvre C; Soubrier F; Lompré AM; Nadaud S
Aging Cell; 2011 Apr; 10(2):220-32. PubMed ID: 21108734
[TBL] [Abstract][Full Text] [Related]
15. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
16. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
[TBL] [Abstract][Full Text] [Related]
17. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin1 (Sirt1) promotes cortical bone formation by preventing β-catenin sequestration by FoxO transcription factors in osteoblast progenitors.
Iyer S; Han L; Bartell SM; Kim HN; Gubrij I; de Cabo R; O'Brien CA; Manolagas SC; Almeida M
J Biol Chem; 2014 Aug; 289(35):24069-78. PubMed ID: 25002589
[TBL] [Abstract][Full Text] [Related]
19. Mapping of the Wnt/β-catenin/TCF response elements in the human versican promoter.
Rahmani M; Carthy JM; McManus BM
Methods Mol Biol; 2012; 836():35-52. PubMed ID: 22252626
[TBL] [Abstract][Full Text] [Related]
20. Functional interaction between beta-catenin and FOXO in oxidative stress signaling.
Essers MA; de Vries-Smits LM; Barker N; Polderman PE; Burgering BM; Korswagen HC
Science; 2005 May; 308(5725):1181-4. PubMed ID: 15905404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
